Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Efficacy of IARULIL® in the Treatment of Recurrent Cystitis Refractory to Escherichia Coli Extract
Phase 4
Completed
- Conditions
- Recurrent Cystitis
- Interventions
- Drug: hyaluronic acid and chondroitin sulphate
- First Posted Date
- 2015-02-19
- Last Posted Date
- 2019-12-02
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 105
- Registration Number
- NCT02366676
- Locations
- 🇰🇷
Samsung Medical Center, Seoul,, Korea, Republic of
XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy
- First Posted Date
- 2015-01-30
- Last Posted Date
- 2019-05-20
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 67
- Registration Number
- NCT02350686
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Phase II Study of Refametinib, a MEK Inhibitor, as Second-line Treatment in Advanced Biliary Tract Adenocarcinoma
- First Posted Date
- 2015-01-26
- Last Posted Date
- 2017-04-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 4
- Registration Number
- NCT02346032
Safety and Clinical Activity of Lapatinib in Patients With HER2-positive Refractory Advanced Cancer
- First Posted Date
- 2015-01-21
- Last Posted Date
- 2017-02-17
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 7
- Registration Number
- NCT02342587
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Safety and Efficacy of Allogenic Umbilical Cord Blood-derived Mesenchymal Stem Cell Product
Early Phase 1
- Conditions
- Osteochondral Lesion of Talus
- Interventions
- Biological: Cartistem
- First Posted Date
- 2015-01-14
- Last Posted Date
- 2015-01-14
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 28
- Registration Number
- NCT02338375
- Locations
- 🇰🇷
Samsung Medical Center, Gangnam-Gu, Seoul, Korea, Republic of
An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP
- First Posted Date
- 2015-01-14
- Last Posted Date
- 2015-01-14
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT02338414
Could the Stroke Volume Variation Predict a Fluid Responsiveness in Thoracotomy?
Completed
- Conditions
- Pulmonary NeoplasmPulmonary Tuberculosis
- Interventions
- Other: fluid loadingProcedure: thoracotomyProcedure: thoracoscopic pulmonary lobectomy
- First Posted Date
- 2015-01-05
- Last Posted Date
- 2016-10-07
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 79
- Registration Number
- NCT02331056
- Locations
- 🇰🇷
Samsung medical center, Seoul, Korea, Republic of
Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic Resection
Completed
- Conditions
- Liver DiseaseHepatocellular Carcinoma
- Interventions
- Other: hartmann solution
- First Posted Date
- 2015-01-01
- Last Posted Date
- 2015-07-13
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 72
- Registration Number
- NCT02329821
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
A Phase II Clinical Trial of Reduced Port Totally Laparoscopic Distal Gastrectomy With D2 Lymph Node Dissection
Phase 2
- Conditions
- Gastric Cancer
- Interventions
- Procedure: reduced port laparoscopic distal gastrectomy
- First Posted Date
- 2014-12-08
- Last Posted Date
- 2014-12-08
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 67
- Registration Number
- NCT02311595
Prompt Or Watchful Monitoring for Hepatitis B Virus Related Hepatocellular Carcinoma Without Elevated viRal Load
- First Posted Date
- 2014-12-04
- Last Posted Date
- 2014-12-04
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 124
- Registration Number
- NCT02308319
© Copyright 2025. All Rights Reserved by MedPath